Alkaloids with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling.
Smith B BabiakaConrad V SimobenKennedy O AbugaJames A MbahRajshekhar KarpoormathDennis OngaroraHannington MugoElvis MonyaFidelis Cho-NgwaWolfgang SipplE Joel LoveridgeFidele Ntie-KangPublished in: Molecules (Basel, Switzerland) (2020)
A new iboga-vobasine-type isomeric bisindole alkaloid named voacamine A (1), along with eight known compounds-voacangine (2), voacristine (3), coronaridine (4), tabernanthine (5), iboxygaine (6), voacamine (7), voacorine (8) and conoduramine (9)-were isolated from the stem bark of Voacangaafricana. The structures of the compounds were determined by comprehensive spectroscopic analyses. Compounds 1, 2, 3, 4, 6, 7 and 8 were found to inhibit the motility of both the microfilariae (Mf) and adult male worms of Onchocerca ochengi, in a dose-dependent manner, but were only moderately active on the adult female worms upon biochemical assessment at 30 μM drug concentrations. The IC50 values of the isolates are 2.49-5.49 µM for microfilariae and 3.45-17.87 µM for adult males. Homology modeling was used to generate a 3D model of the O. ochengi thioredoxin reductase target and docking simulation, followed by molecular dynamics and binding free energy calculations attempted to offer an explanation of the anti-onchocercal structure-activity relationship (SAR) of the isolated compounds. These alkaloids are new potential leads for the development of antifilarial drugs. The results of this study validate the traditional use of V. africana in the treatment of human onchocerciasis.
Keyphrases
- molecular dynamics
- density functional theory
- structure activity relationship
- endothelial cells
- molecular dynamics simulations
- molecular docking
- childhood cancer
- high resolution
- staphylococcus aureus
- risk assessment
- cystic fibrosis
- induced pluripotent stem cells
- young adults
- drug induced
- combination therapy
- smoking cessation